Bentley Pharmaceuticals to Release First-Quarter 2008 Financial Results on May 8, 2008
Bentley Pharmaceuticals zu myNews hinzufügen Was ist das?
Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical
company, today announced that management will host a conference call to
discuss first-quarter 2008 financial results on Thursday, May 8, 2008,
at 10:00 a.m. (ET). On the call, the Company will also provide an update
on the ongoing process of separating its drug delivery business from its
generic pharmaceuticals business. Bentley will release its results for
the three months ended March 31, 2008, before the market opens on that
day.
To participate on the live call, please dial (888) 332-7254 or (973)
582-2856 for international callers. The access code for the call is
45706774. The conference call will also be webcast live and may be
accessed via Bentley’s website, www.bentleypharm.com.
A telephone replay will be available for 30 days by dialing (800)
642-1687 or (706) 645-9291 for international callers. Please reference
reservation number 45706774. A replay of the conference call also will
be available on Bentley’s website for 30 days.
Bentley Pharmaceuticals, Inc. is a specialty pharmaceutical company
focused on advanced drug delivery technologies and generic
pharmaceutical products. Bentley's proprietary drug delivery
technologies enhance the absorption of pharmaceutical compounds across
various membranes. Bentley manufactures and markets a growing portfolio
of generic and branded generic pharmaceuticals in Europe for the
treatment of cardiovascular, gastrointestinal, infectious and central
nervous system diseases through its subsidiaries -- Laboratorios Belmac,
Laboratorios Davur, Laboratorios Rimafar and Bentley Pharmaceuticals
Ireland. Bentley also manufactures and markets active pharmaceutical
ingredients through its subsidiary, Bentley API.
Additional information regarding Bentley Pharmaceuticals may be obtained
through Bentley's website at www.bentleypharm.com.
